Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

COG-01 Phenotypic variation in 
ALS-FTD and effect on survival.

Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):301-308. doi: 10.1080/21678421.2019.1647000.

PMID:
31702468
2.

Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.

McCann EP, Fifita JA, Grima N, Galper J, Mehta P, Freckleton SE, Zhang KY, Henden L, Hogan AL, Chan Moi Fat S, Wu SS, Jagaraj CJ, Berning BA, Williams KL, Twine NA, Bauer D, Piguet O, Hodges J, Kwok JBJ, Halliday GM, Kiernan MC, Atkin J, Rowe DB, Nicholson GA, Walker AK, Blair IP, Yang S.

J Neurol Neurosurg Psychiatry. 2019 Nov 5. pii: jnnp-2019-321790. doi: 10.1136/jnnp-2019-321790. [Epub ahead of print]

PMID:
31690696
3.

Sound of the crowd: wisdom of neurologists revisited.

Dharmadasa T, Kiernan MC.

Pract Neurol. 2019 Oct 24. pii: practneurol-2019-002384. doi: 10.1136/practneurol-2019-002384. [Epub ahead of print] No abstract available.

PMID:
31649104
4.

Inherited Neuropathies.

Carroll AS, Burns J, Nicholson G, Kiernan MC, Vucic S.

Semin Neurol. 2019 Oct;39(5):620-639. doi: 10.1055/s-0039-1693006. Epub 2019 Oct 22.

PMID:
31639845
5.

TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions.

Yang Y, Halliday GM, Kiernan MC, Tan RH.

Neurology. 2019 Nov 5;93(19):e1748-e1755. doi: 10.1212/WNL.0000000000008439. Epub 2019 Oct 16.

PMID:
31619481
6.

Milestones.

Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1189. doi: 10.1136/jnnp-2019-321711. Epub 2019 Oct 3. No abstract available.

PMID:
31582463
7.

Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.

Issar T, Arnold R, Kwai NCG, Walker S, Yan A, Borire AA, Poynten AM, Pussell BA, Endre ZH, Kiernan MC, Krishnan AV.

Clin Neurophysiol. 2019 Nov;130(11):2088-2095. doi: 10.1016/j.clinph.2019.08.005. Epub 2019 Aug 22.

PMID:
31541986
8.

Multifocal motor neuropathy: controversies and priorities.

Yeh WZ, Dyck PJ, van den Berg LH, Kiernan MC, Taylor BV.

J Neurol Neurosurg Psychiatry. 2019 Sep 11. pii: jnnp-2019-321532. doi: 10.1136/jnnp-2019-321532. [Epub ahead of print] Review.

PMID:
31511307
9.

Measurement of axonal excitability: Consensus guidelines.

Kiernan MC, Bostock H, Park SB, Kaji R, Krarup C, Krishnan AV, Kuwabara S, Lin CS, Misawa S, Moldovan M, Sung J, Vucic S, Wainger BJ, Waxman S, Burke D.

Clin Neurophysiol. 2019 Aug 2. pii: S1388-2457(19)31170-8. doi: 10.1016/j.clinph.2019.07.023. [Epub ahead of print] Review.

10.

Neural networks associated with body composition in frontotemporal dementia.

Ahmed RM, Landin-Romero R, Liang CT, Keogh JM, Henning E, Strikwerda-Brown C, Devenney EM, Hodges JR, Kiernan MC, Farooqi IS, Piguet O.

Ann Clin Transl Neurol. 2019 Sep;6(9):1707-1717. doi: 10.1002/acn3.50869. Epub 2019 Aug 28.

11.

Regional motor cortex dysfunction in amyotrophic lateral sclerosis.

Menon P, Yiannikas C, Kiernan MC, Vucic S.

Ann Clin Transl Neurol. 2019 Aug;6(8):1373-1382. doi: 10.1002/acn3.50819. Epub 2019 Jun 28.

12.

CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Ke YD, Chan G, Stefanoska K, Au C, Bi M, Müller J, Przybyla M, Feiten A, Prikas E, Halliday GM, Piguet O, Kiernan MC, Kassiou M, Hodges JR, Loy CT, Mattick JS, Ittner A, Kril JJ, Sutherland GT, Ittner LM.

J Biol Chem. 2019 Sep 20;294(38):14149-14162. doi: 10.1074/jbc.RA118.005263. Epub 2019 Jul 31.

PMID:
31366728
13.

Consensus for experimental design in electromyography (CEDE) project: Electrode selection matrix.

Besomi M, Hodges PW, Van Dieën J, Carson RG, Clancy EA, Disselhorst-Klug C, Holobar A, Hug F, Kiernan MC, Lowery M, McGill K, Merletti R, Perreault E, Søgaard K, Tucker K, Besier T, Enoka R, Falla D, Farina D, Gandevia S, Rothwell JC, Vicenzino B, Wrigley T.

J Electromyogr Kinesiol. 2019 Oct;48:128-144. doi: 10.1016/j.jelekin.2019.07.008. Epub 2019 Jul 19.

PMID:
31352156
14.

Sonographic assessment of nerve blood flow in diabetic neuropathy.

Borire AA, Issar T, Kwai NC, Visser LH, Simon NG, Poynten AM, Kiernan MC, Krishnan AV.

Diabet Med. 2019 Jul 23. doi: 10.1111/dme.14085. [Epub ahead of print]

PMID:
31338857
15.

Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients.

Timmins HC, Li T, Kiernan MC, Horvath LG, Goldstein D, Park SB.

J Pain. 2019 Jul 17. pii: S1526-5900(19)30765-5. doi: 10.1016/j.jpain.2019.06.011. [Epub ahead of print] Review.

PMID:
31325646
16.

Neuroinflammation in frontotemporal dementia.

Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kassiou M, Kril JJ.

Nat Rev Neurol. 2019 Sep;15(9):540-555. doi: 10.1038/s41582-019-0231-z. Epub 2019 Jul 19. Review.

PMID:
31324897
17.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Sep;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. Epub 2019 Jun 22.

PMID:
31301633
18.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):595-604. doi: 10.1080/21678421.2019.1632899. Epub 2019 Jul 8.

PMID:
31284774
19.

Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.

Vucic S, Westeneng HJ, Al-Chalabi A, Van Den Berg LH, Talman P, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):532-537. doi: 10.1080/21678421.2018.1556697. Epub 2019 Jul 8.

PMID:
31284763
20.

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.

Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kril JJ, Kassiou M.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3161. doi: 10.3390/ijms20133161. Review.

21.

Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period.

Kiernan MC, Ziemann U, Eisen A.

Muscle Nerve. 2019 Sep;60(3):232-235. doi: 10.1002/mus.26617. Epub 2019 Jul 5.

PMID:
31233613
22.

Marco Polo of Australian neurology.

Kiernan MC, Goadsby PJ, Burke D.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):627-628. doi: 10.1136/jnnp-2019-320989. Epub 2019 May 2. No abstract available.

PMID:
31048340
23.

Patient Editorial Board for JNNP.

Riggare S, Thurbon R, Roman S, Richards T, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):369-370. doi: 10.1136/jnnp-2019-320453. No abstract available.

PMID:
30967489
24.

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia.

Ahmed RM, Phan K, Highton-Williamson E, Strikwerda-Brown C, Caga J, Ramsey E, Zoing M, Devenney E, Kim WS, Hodges JR, Piguet O, Halliday GM, Kiernan MC.

Ann Clin Transl Neurol. 2019 Jan 31;6(3):486-495. doi: 10.1002/acn3.721. eCollection 2019 Mar.

25.

Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.

Garg N, Park SB, Howells J, Vucic S, Yiannikas C, Mathey EK, Nguyen T, Noto Y, Barnett MH, Krishnan AV, Spies J, Bostock H, Pollard JD, Kiernan MC.

Eur J Neurol. 2019 Aug;26(8):1121-1129. doi: 10.1111/ene.13953. Epub 2019 Apr 26.

PMID:
30882969
26.

The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.

Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM.

Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.

PMID:
30770429
27.

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis.

McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1011-1020. doi: 10.1136/jnnp-2018-319581. Epub 2019 Feb 13. Review.

28.

The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS.

Dharmadasa T, Matamala JM, Howells J, Simon NG, Vucic S, Kiernan MC.

Neurosci Lett. 2019 Apr 23;699:84-90. doi: 10.1016/j.neulet.2019.01.050. Epub 2019 Jan 30.

PMID:
30710665
29.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
30.

Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Long Z, Irish M, Piguet O, Kiernan MC, Hodges JR, Burrell JR.

J Neurol. 2019 Apr;266(4):921-933. doi: 10.1007/s00415-019-09216-0. Epub 2019 Feb 1.

PMID:
30707358
31.

Vasculitic neuropathy: Comparison of clinical predictors with histopathological outcome.

Nathani D, Barnett MH, Spies J, Pollard J, Wang MX, Kiernan MC.

Muscle Nerve. 2019 Jun;59(6):643-649. doi: 10.1002/mus.26431. Epub 2019 Feb 23.

PMID:
30702153
32.

Cerebellar tract alterations in PLS and ALS.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):281-284. doi: 10.1080/21678421.2018.1562554. Epub 2019 Jan 21.

PMID:
30663900
33.

Functional Biomarkers for Amyotrophic Lateral Sclerosis.

Huynh W, Dharmadasa T, Vucic S, Kiernan MC.

Front Neurol. 2019 Jan 4;9:1141. doi: 10.3389/fneur.2018.01141. eCollection 2018. Review.

34.

Predictors of survival and progression in behavioural variant frontotemporal dementia.

Agarwal S, Ahmed RM, D'Mello M, Foxe D, Kaizik C, Kiernan MC, Halliday GM, Piguet O, Hodges JR.

Eur J Neurol. 2019 May;26(5):774-779. doi: 10.1111/ene.13887. Epub 2019 Jan 29.

PMID:
30565360
35.

Utility of threshold tracking transcranial magnetic stimulation in ALS.

Vucic S, van den Bos M, Menon P, Howells J, Dharmadasa T, Kiernan MC.

Clin Neurophysiol Pract. 2018 Nov 17;3:164-172. doi: 10.1016/j.cnp.2018.10.002. eCollection 2018. Review.

36.

Frontostriatal grey matter atrophy in amyotrophic lateral sclerosis A visual rating study.

Radakovic R, Puthusseryppady V, Flanagan E, Kiernan MC, Mioshi E, Hornberger M.

Dement Neuropsychol. 2018 Oct-Dec;12(4):388-393. doi: 10.1590/1980-57642018dn12-040008.

37.

Motor neurone disease.

Dharmadasa T, Matamala JM, Huynh W, Zoing MC, Kiernan MC.

Handb Clin Neurol. 2018;159:345-357. doi: 10.1016/B978-0-444-63916-5.00022-7. Review.

PMID:
30482326
38.

Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: A systematic review.

Gu Y, Dennis SM, Kiernan MC, Harmer AR.

Diabetes Metab Res Rev. 2019 Feb;35(2):e3099. doi: 10.1002/dmrr.3099. Epub 2018 Dec 7.

PMID:
30462877
39.

The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis.

Caga J, Hsieh S, Highton-Williamson E, Zoing MC, Ramsey E, Devenney E, Ahmed RM, Hogden A, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):599-605. doi: 10.1080/21678421.2018.1497659. Epub 2018 Oct 29.

PMID:
30369270
40.

Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS.

Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S.

Neurology. 2018 Oct 30;91(18):e1669-e1676. doi: 10.1212/WNL.0000000000006438. Epub 2018 Oct 3.

PMID:
30282772
41.

Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members.

Devenney EM, Ahmed RM, Halliday G, Piguet O, Kiernan MC, Hodges JR.

Neurology. 2018 Oct 16;91(16):e1498-e1507. doi: 10.1212/WNL.0000000000006344. Epub 2018 Sep 26.

PMID:
30258023
42.

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.

Vincent A, Pettingill P, Pettingill R, Lang B, Birch R, Waters P, Irani SR, Buckley C, Watanabe O, Arimura K, Kiernan MC.

JAMA Neurol. 2018 Dec 1;75(12):1519-1527. doi: 10.1001/jamaneurol.2018.2681.

43.

Potassium control in chronic kidney disease: implications for neuromuscular function.

Arnold R, Pianta TJ, Pussell BA, Endre Z, Kiernan MC, Krishnan AV.

Intern Med J. 2019 Jul;49(7):817-825. doi: 10.1111/imj.14114. Review.

PMID:
30230667
44.

In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis.

Howells J, Matamala JM, Park SB, Garg N, Vucic S, Bostock H, Burke D, Kiernan MC.

J Physiol. 2018 Nov;596(22):5379-5396. doi: 10.1113/JP276624. Epub 2018 Oct 17.

45.

Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning.

Ahmed RM, Goldberg ZL, Kaizik C, Kiernan MC, Hodges JR, Piguet O, Irish M.

J Neurol. 2018 Nov;265(11):2562-2572. doi: 10.1007/s00415-018-9024-3. Epub 2018 Aug 28.

PMID:
30167881
46.

Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels.

Garg N, Park SB, Howells J, Noto YI, Vucic S, Yiannikas C, Tomlinson SE, Huynh W, Simon NG, Mathey EK, Spies J, Pollard JD, Krishnan AV, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2162-2169. doi: 10.1016/j.clinph.2018.07.021. Epub 2018 Aug 10.

PMID:
30144659
47.

Fasciculation intensity and disease progression in amyotrophic lateral sclerosis.

Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2149-2154. doi: 10.1016/j.clinph.2018.07.015. Epub 2018 Aug 2.

PMID:
30114663
48.

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1250-1258. doi: 10.1136/jnnp-2018-318625. Epub 2018 Jul 26.

PMID:
30049750
49.

Comparison of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lateral sclerosis.

Noto YI, Garg N, Li T, Timmins HC, Park SB, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Yiannikas C, Vucic S, Kiernan MC.

Muscle Nerve. 2018 Dec;58(6):777-783. doi: 10.1002/mus.26301. Epub 2018 Oct 15.

PMID:
30019401
50.

Cortical excitability varies across different muscles.

Menon P, Kiernan MC, Vucic S.

J Neurophysiol. 2018 Sep 1;120(3):1397-1403. doi: 10.1152/jn.00148.2018. Epub 2018 Jul 5.

Supplemental Content

Loading ...
Support Center